GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Study Identifies Occupational Stress, Psychological Safety, and Digital Fatigue as Key Factors Affecting Nurses’ Job Performance

by GOAI
Share To

A recent study conducted by Demir et al. has identified key factors that significantly impact nurses’ job performance, including occupational stress, psychological safety, and digital fatigue. The research highlights how these elements interact to influence the effectiveness of nurses in their roles, which directly affects patient outcomes and the overall quality of healthcare services.

The study examines the relationship between perceived occupational stress and its effect on nurses’ ability to perform their duties efficiently. It also explores the role of psychological safety—defined as a work environment where individuals feel safe to express concerns or make mistakes without fear of negative consequences—and its contribution to job performance. Additionally, the research addresses digital fatigue, a growing concern in modern healthcare settings due to increased reliance on technology for patient care and administrative tasks. The findings underscore the importance of understanding these interconnected factors to better support nursing staff and maintain high standards in healthcare delivery.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top